According to a new report, published by KBV research, The Global Peripheral Vascular Stents Market size is expected to reach $2.7 billion by 2030, rising at a market growth of 7.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 2,468.7 thousand units, experiencing a growth of 6.8% (2019-2022).
The Balloon-expandable Stents segment is generating the maximum revenue in the Global Peripheral Vascular Stents Market by Mode of Delivery in 2022; thereby, achieving a market value of $1.5 billion by 2030. Balloon-expanding stents offer significant benefits by allowing precise and controlled expansion within the affected blood vessel. This property assures the optimal vessel scaffolding, resulting in increased blood flow and a decreased risk of re-narrowing or restenosis.
The Ambulatory Surgical Centers segment would witness a CAGR of 7.8% during (2023 - 2030). Ambulatory care facilities have increasingly influenced peripheral vascular stent acceptance and use. These centers offer an expedient and cost-effective alternative to traditional hospital settings for various outpatient procedures, including the implantation of peripheral vascular stents.
The Iliac Artery Stents segment is leading the Global Peripheral Vascular Stents Market by Product in 2022; thereby, achieving a market value of $896.8 million by 2030. Iliac artery disease, a condition in which the iliac arteries constrict or become obstructed and restrict blood flow to the legs, is usually treated using iliac artery stents. Symptoms of iliac artery disease can include leg pain, claudication (leg cramping during exercise), and, in severe cases, critical limb ischemia. Various iliac artery stents are available, including bare-metal stents (BMS) and DES. DES, which releases medication to prevent restenosis, is often preferred for its ability to reduce the need for repeat procedures.
The Bioabsorbable Stents segment is experiencing a CAGR of 8.9% during (2023 - 2030). The bioabsorbable stents segment covered a considerable revenue share in the peripheral vascular stents market in 2022. The segment of bioabsorbable stents is also anticipated to expand significantly over the forecast period. Interventional cardiology has witnessed a revolutionary development with the introduction of bioabsorbable stents. Progressively dissolving in the body eliminates long-term risks such as in-stent restenosis and late-stent thrombosis, decreasing the likelihood of adverse events.
The North America region dominated the Global Peripheral Vascular Stents Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.0 billion by 2030. The Europe region is anticipated to grow at a CAGR of 7.1% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 8.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/peripheral-vascular-stents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Stryker Corporation, Cook Medical, Inc. (Cook Group), MicroPort Scientific Corporation, LifeTech Scientific Corporation and iVascular S.L.U.
By Mode of Delivery (Volume, Thousand Units, USD Million, 2019-2030)
By End-use (Volume, Thousand Units, USD Million, 2019-2030)
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Stents Type (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings 
